Helen K. Ellias

Insider Reports History

Entity
Individual
Location
2100 East 54 Th Street North, Sioux Falls, SD
Signature
/s/ Katie Ellias
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen K. Ellias:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Common Stock 2.86M $2.51M $0.88 Nov 24, 2023 Indirect
SAB Biotherapeutics, Inc. Director Stock Option (right to buy) 35K Nov 1, 2024 Direct
SAB Biotherapeutics, Inc. Director Series A-1 Convertible Preferred Stock 0 $1,000.00 Nov 24, 2023 Indirect

Insider Reports Filed by Helen K. Ellias

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Nov 1, 2024 2 $0 4 Nov 5, 2024 Director
SABS SAB Biotherapeutics, Inc. Nov 24, 2023 2 -$1.8M 4 Nov 28, 2023 Director
SABS SAB Biotherapeutics, Inc. Nov 14, 2023 0 $0 3 Nov 22, 2023 Director